对数据集,优化策略和学习算法进行审查,以分析阿尔茨海默氏症痴呆症检测
Vanaja Thulasimani1, Kogilavani Shanmugavadivel1, Jaehyuk Cho2
1Department of Artificial Intelligence, Kongu Engineering College, Perundurai, Tamilnadu, India.
Neuropsychiatric disease and treatment
|November 26, 2024
概括
早期发现阿尔茨海默氏症痴呆症 (AD) 对于及时干预至关重要. 这项研究分析了多式成像,机器学习和优化技术,以提高这种渐进的神经疾病的诊断准确性.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 阿尔茨海默氏症痴呆症 (AD) 是一种进展性神经疾病,影响记忆和认知,构成了全球重大公共卫生挑战.
- 早期和准确的痴呆症检测对于及时干预,治疗计划以及将其与具有类似症状的其他疾病区分开来至关重要.
- 检测方法的进步推动了医学研究,帮助识别生物标志物,改进诊断工具,并开发用于痴呆症诊断的创新技术.
研究的目的:
- 批判性地分析多式联络成像数据集,学习算法和阿尔茨海默氏症痴呆症检测的优化技术.
- 了解使用MRI,PET和EEG等用于痴呆症检测的各种成像模式的进步和挑战.
- 评估机器学习,深度学习,转移学习和生成对抗网络,用于分析痴呆症检测中的多模式成像数据.
主要方法:
- 对多式成像数据集 (MRI,PET,EEG) 的批判性分析.
- 机器学习算法,深度学习模型,转移学习和生成对抗网络的评估.
- 检查优化技术,包括优化算法和超参数调整用于图像处理和分析.
主要成果:
- 该研究提供了使用多式成像和人工智能检测阿尔茨海默氏症痴呆症的当前方法的全面概述.
- 它强调了各种机器学习和深度学习方法在分析复杂的成像数据中的有效性.
- 优化技术对模型性能和痴呆症检测中的概括的影响得到了批判性研究.
结论:
- 提高痴呆症检测方法对于应对医疗保健挑战,实现及时干预和提高诊断准确性至关重要.
- 持续的研究和多式成像分析的技术进步对于对抗AD等神经退行性疾病至关重要.
- 这项工作有助于通过改进检测策略,提高神经退行性疾病的诊断准确性和研究.
更多相关视频
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
40.2K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
相关概念视频
Dementia
96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
96
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
